FDA Recall: American Regent, Inc. Animal Health Adequan Canine Injection and for Visible glass fiber material in the product
Source: FDA
File Your Claim Now

FDA Recall: American Regent, Inc. Animal Health Adequan Canine Injection and for Visible glass fiber material in the product

American Regent, Inc. Animal Health August 03, 2026

FDA Recall: American Regent Adequan Canine & Adequan i.m. Injections for Glass-Fiber Contamination

Need-to-know: American Regent, Inc. Animal Health has voluntarily recalled two lots of Adequan Canine and two lots of Adequan i.m. injections after in-house testing revealed visible glass fibers floating in some vials. If your bottle matches an affected lot, stop using it immediately, quarantine the product, and contact your veterinarian for next steps.

Why the Adequan recall was issued

Retained-sample testing detected glass-fiber fragments in select vials. Injecting particulate matter can trigger local irritation, swelling, infection, or abscess formation at the injection site in dogs or horses. Although no injuries have been reported, the company and the U.S. Food & Drug Administration (FDA) initiated the recall out of an abundance of caution.

Adequan recall lot numbers and product details

Only the lots listed below are included in this nationwide recall. Vials from any other lot remain approved for use.

  • Adequan Canine Injection, 100 mg/mL, 5 mL multi-dose vial
    • Lot 3369 — distributed 05/22/2024 — expires 10/31/2026
    • Lot 25011 — distributed 04/14/2025 — expires 12/31/2027
  • Adequan i.m. Injection (equine), 500 mg/5 mL single-dose vial
    • Lot 24416 — distributed 05/08/2025 — expires 11/30/2027
    • Lot 25265P — distributed 01/22/2026 — expires 03/31/2027

Immediate actions for pet owners and veterinarians

  • Quarantine and discontinue use of Adequan vials with the affected lot numbers.
  • If an animal has already received a recalled dose, monitor the injection site for pain, swelling, heat, or drainage and consult your veterinarian promptly.
  • Arrange product return or disposal via your purchasing distributor or the manufacturer’s instructions.
  • Report suspected adverse events to American Regent Pharmacovigilance (animalhealth@americanregent.com, 888-354-4857) and to the FDA (1-888-FDA-VETS or the online portal).

Customer-service & refund contacts

For replacement product or credit, call American Regent Customer Service at 800-645-1706 (Mon–Thu 8 a.m.–6 p.m. ET; Fri until 4 p.m.) or email cs@americanregent.com.

Sources

Official FDA recall images for Adequan

Recalled Adequan i.m. Injection single-dose vial
Source: FDA
Recalled Adequan Canine Injection multi-dose vial
Source: FDA

Adequan recall FAQ

Which Adequan lots are being recalled?
Lots 3369 and 25011 of Adequan Canine, and lots 24416 and 25265P of Adequan i.m. are impacted.
Is it safe to keep giving Adequan from lots that are not on the recall list?
Yes. Adequan vials outside the four affected lot numbers remain safe for use when administered as directed by a veterinarian.
What health risks does the Adequan glass-fiber recall pose to my dog or horse?
Injected glass particles may cause localized irritation, swelling, infection, or abscesses at the injection site.
Have any adverse reactions from the recalled Adequan lots been reported?
No injuries linked to the recalled lots have been reported as of the July 31 announcement.
How do I obtain a refund or replacement for recalled Adequan vials?
Contact American Regent Customer Service at 800-645-1706 or email cs@americanregent.com for return and credit instructions.
What should veterinarians do with recalled Adequan inventory?
Immediately quarantine the affected lots, halt dispensing, notify clients, and arrange returns through your distributor or directly with American Regent.

File Your Claim Now